Aytu Biopharma (AYTU) Net Income (2010 - 2025)
Aytu Biopharma (AYTU) reported Net Income of $62000.0 for Q2 2025, up 105.0% year-over-year from $30243.3 in Q2 2024, and up 14.81% quarter-over-quarter from $54000.0 in Q1 2025.
Aytu Biopharma (AYTU) Net Income (2010 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has 16 years of Net Income data on file, last reported at $62000.0 in Q2 2025.
- Net Income for Q2 2025 came in at $62000.0, up 105.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $62000.0 (up 109.1% YoY), and the FY2025 annual result was $620000.0, up 118.65% from the prior year.
- Net Income improved to $62000.0 in Q2 2025 per AYTU's latest filing, from $54000.0 in the prior quarter.
- Over five years, Net Income peaked at $381000.0 in Q3 2024 and troughed at -$53.3 million in Q1 2022.
- A 5-year average of -$8.7 million and a median of -$1.2 million in 2024 frame the typical range for Net Income.
- The sharpest annual moves came in 2021 and 2024: Net Income plunged 546.8% in 2021, then surged 158.89% in 2024.
- A 5-year view of Net Income shows it stood at -$11.5 million in 2021, then soared by 42.04% to -$6.7 million in 2022, then jumped by 87.46% to -$839000.0 in 2023, then surged by 114.66% to $123000.0 in 2024, then slumped by 49.59% to $62000.0 in 2025.
- Business Quant data shows AYTU's Net Income at $62000.0 in Q2 2025, $54000.0 in Q1 2025, and $123000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 62,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -599,000.00 |
| Dec 31, 2023 | -839,000.00 |
| Sep 30, 2023 | -647,000.00 |
| Jun 30, 2023 | -2.58 Mn |
| Mar 31, 2023 | -7.20 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | -16.09 Mn |
| Mar 31, 2022 | -53.29 Mn |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -27.85 Mn |
| Jun 30, 2021 | -18.74 Mn |
| Dec 31, 2020 | -9.53 Mn |
| Sep 30, 2020 | -4.31 Mn |
| Jun 30, 2020 | -8.06 Mn |